Advanced Search
Korean J Pediatr 2017 July;60(7) :203-207.
Published online 2017 July 15.        doi:
Chorioamnionitis: Is a major player in the development of bronchopulmonary dysplasia?
Chang Won Choi
Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea
Corresponding Author: Chang Won Choi ,Tel: +82-31-787-7286, Fax: +82-31-787-4054, Email:
Copyright © 2017 by The Korean Pediatric Society
Chorioamnionitis is an inflammation in the fetal membranes or placenta. When chorioamnionitis develops, fetal lungs are exposed to inflammatory cytokines and mediators via amniotic fluid. Because inflammation plays a pivotal role in the development of bronchopulmonary dysplasia (BPD), a chronic lung disease of prematurity, fetal lung inflammation induced by chorioamnionitis has been considered to be one of the major pathogenetic factors for BPD. Although there have been a number of studies that demonstrated the relationship between chorioamnionitis and BPD, there are still controversies on this issue. The controversies on the relationship between chorioamnionitis and BPD arise from not-unified definitions of chorioamnionitis and BPD, different study populations, and the proportion of contribution between inflammation and infectious microorganisms. The publication bias also contributes to the controversies. Clinical trials targeting chorioamnionitis or microorganisms that cause chorioamnionitis will answer on the actual relationship between chorioamnionitis and BPD and provide a novel prophylactic strategy against BPD based on that relationship.
Keywords: Chorioamnionitis | Bronchopulmonary dysplasia | Ureaplasma
PDF Links  PDF Links
Full text via DOI  Full text via DOI
Download Citation  Download Citation
Supplementary Material  Supplementary Material
The efficacy and safety of Montelukast sodium in the prevention of bronchopulmonary dysplasia  2015 September;58(9)
The effects of neonatal ventilator care or maternal chorioamnionitis on the development of bronchopulmonary dysplasia  2009 August;52(8)
Montelukast as an add-on therapy in bronchopulmonary dysplasia  2009 February;52(2)
Risk Factors and Outcome of Bronchopulmonary Dysplasia  1994 January;37(1)
Register for e-submission
Register here to access the e-submission system of Korean J Pediatr for authors and reviewers.
Manuscript Submission
To submit a manuscript, please visit the Korean J Pediatr e-submission management system at, read the Instructions for Authors, and log into the Korean J Pediatr e-submission system. For assistance with manuscript submission, please contact:
Free archive
Anyone may access any past or current articles without logging in.
Korean Pediatric Society Office
#1606, Seocho World Officetel, 19 Seoun-ro, Seocho-gu, Seoul 137-070, Korea
TEL : +82-2-3473-7305    FAX : +82-2-3473-7307   E-mail:
BrowseCurrent IssueFor Authors and ReviewersAbout
Copyright© The Korean Pediatric Society. All right reserved.